Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:01 PM
Ignite Modification Date:
2025-12-24 @ 7:01 PM
NCT ID:
NCT01515657
Eligibility Criteria:
Inclusion Criteria:
* Adults 21-79
* Body mass index (BMI) of 30-40 kg/m2
* Non-insulin-dependent type-2 diabetics (as confirmed by hemoglobin A1c (HbA1c) of \> 6.4% and/or fasting plasma glucose of \>125 mg/dL or current anti-diabetic medication)
* AA-induced platelet aggregation response of \>60% within 3 hours prior to initial dose of study drug administration
Exclusion Criteria:
* Contraindications to aspirin
* Previous history of vascular disease
* Patient requires insulin
* Use of non-steroidal anti-inflammatory drugs, anti-secretory agents, antacids, and salicylate-containing nutritional supplements within 2 weeks of randomization
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
21 Years
Maximum Age:
79 Years
Study:
NCT01515657
Study Brief:
Protocol Section:
NCT01515657